
Adam Sullivan is President and Chief Executive Officer of Core Scientific, Inc., roles he has held since May 2023 and August 2023, respectively, and has served on the company's Board of Directors since January 23, 2024. He is 33 years old.
From 2017 to 2023, Sullivan was Managing Director and Head of Digital Assets and Infrastructure Group at XMS Capital Partners, a financial advisory firm, where he oversaw more than $5 billion in transactions. In this capacity, he represented Power and Digital Infrastructure Acquisition Corporation in its 2021 acquisition of Core Scientific Holding Co. and related subsidiary entities.
Sullivan holds a B.A. in Financial Economics from the University of Rochester.
Biography extracted from Core Scientific PRE 14A filed 2025-03-12 View cached copy (2026-08-31)Live source ↗
Photo: www.corescientific.com (Core Scientific official site) · retrieved 2026-08-31 · cached copy · match confidence high
Roles
Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.
| Company | Role | Tenure | Filings |
|---|---|---|---|
| Core Scientific | Chief Executive Officer, Director | 2026-06 → present (3mo) | 2 |
Show 2 underlying filings | |||
Compensation
| Year | Role as filed | Salary | Bonus | Stock awards | Incentive | Other | Total | Source |
|---|---|---|---|---|---|---|---|---|
| 2025 | President and Chief Executive Officer | $815.8K | — | $20.01M | $2.06M | $39.3K | $22.92M | View cached copy (2026-08-31)Live source ↗ |
| 2024 | President and Chief Executive Officer | $563.0K | — | $39.50M | $1.80M | $80.0K | $41.94M | View cached copy (2026-08-31)Live source ↗ |
| 2023 | President and Chief Executive Officer | $378.3K | $500.0K | — | — | $12.5K | $890.8K | View cached copy (2026-08-31)Live source ↗ |
As reported in the company's DEF 14A Summary Compensation Table (SEC Reg S-K Item 402(c)). Stock and option awards are grant-date fair values — what the award was worth on the day it was granted, not cash received and not what it is worth now. Every row here reconciles: its columns add up to the total the filing printed.
Insider transactions
Totals for this person
| Bucket | Invested (shares) | Invested (USD) | Divested (shares) | Divested (USD) | Net direction | Txns | Invested @ last price | Divested @ last price |
|---|---|---|---|---|---|---|---|---|
| All time | - | $0 | 33,607 | $815.3K | ↓ Divested $815.3K | 2 | $0 | $601.2K |
| 2026 | - | $0 | 33,607 | $815.3K | ↓ Divested $815.3K | 2 | $0 | $601.2K |
| 2026-Q2 | - | $0 | 18,023 | $461.2K | ↓ Divested $461.2K | 1 | $0 | $322.4K |
| 2026-Q3 | - | $0 | 15,584 | $354.1K | ↓ Divested $354.1K | 1 | $0 | $278.8K |
Invested = shares acquired (buys, grants, option exercises) — insider adding to the position. Divested = shares reduced (sells, dispositions, tax-withholding) — cash flowing TO the insider. Net direction shows which side wins on dollar terms in each bucket. % of holder's stake not yet computed (pending Form 3/4 holdings ingest). See methodology. The two @ last price columns restate the same share counts at the most recent share price we read (close of 2026-09-04); they are a valuation, not a cash flow, and they move every day the market does.
All transactions
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2026-07-16 | Core Scientific | Tax withholding on vesting | 15,584 | $354,068 | $278.8K |
| 2026-06-30 | Core Scientific | Tax withholding on vesting | 18,023 | $461,209 | $322.4K |
